Related Experiment Video
Updated: Apr 16, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
13.0K
[Cormorbidity in multiple sclerosis and its therapeutic approach]
1Unitat d'Esclerosi Múltiple, Hospital Universitari i Politècnic La Fe, València, España.
Medicina Clinica
|March 4, 2015
Summary
Multiple sclerosis (MS) patients experience more comorbidities, impacting disability and diagnosis. Managing these conditions improves patient outcomes and quality of life.
Area of Science:
- Neurology
- Immunology
- Public Health
Context:
- Multiple sclerosis (MS) is a chronic neurological disease.
- Individuals with MS have a higher incidence of intercurrent conditions.
- Comorbidities can significantly affect MS progression and patient management.
Purpose:
- To highlight the prevalence and impact of comorbidities in MS.
- To emphasize the importance of evaluating and managing concurrent conditions in MS patients.
- To discuss the role of multidimensional scales in assessing patient status.
Summary:
- MS patients develop intercurrent processes three times more frequently than the general population.
- Comorbidities, including autoimmune diseases, general illnesses, and psychiatric disturbances, are common in MS.
- The Charlson index and Disability Expectancy Table (DET) are tools for measuring and managing comorbidities.
Impact:
- Effective management of comorbidities can delay disability progression in MS.
- Addressing comorbidities can expedite MS diagnosis and treatment initiation.
- A holistic approach to patient health, including comorbidity assessment, enhances quality of life for MS patients.
More Related Videos
Related Concept Videos
01:28Drug Therapy
418
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
418
01:24Treatment Strategies for Psychological Disorders
948
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
948
01:20Myasthenia Gravis: Overview and Treatment
3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
01:26Modeling in Therapy
753
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
753
01:26Psychosis: Goals of Pharmacotherapy
688
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
688
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K